Calton & Associates Inc. acquired a new stake in CME Group Inc (NASDAQ:CME) during the 4th quarter, HoldingsChannel reports. The firm acquired 6,910 shares of the financial services provider’s stock, valued at approximately $1,065,000.
Other hedge funds and other institutional investors have also made changes to their positions in the company. Quadrant Private Wealth Management LLC acquired a new stake in CME Group in the fourth quarter worth $5,728,000. Raymond James Trust N.A. raised its holdings in CME Group by 5.4% in the fourth quarter. Raymond James Trust N.A. now owns 15,559 shares of the financial services provider’s stock worth $2,273,000 after purchasing an additional 804 shares during the period. Public Employees Retirement Association of Colorado raised its holdings in CME Group by 5.6% in the fourth quarter. Public Employees Retirement Association of Colorado now owns 63,436 shares of the financial services provider’s stock worth $9,265,000 after purchasing an additional 3,376 shares during the period. Dempze Nancy E acquired a new stake in CME Group in the fourth quarter worth $205,000. Finally, Everence Capital Management Inc. raised its holdings in CME Group by 7.0% in the fourth quarter. Everence Capital Management Inc. now owns 7,563 shares of the financial services provider’s stock worth $1,105,000 after purchasing an additional 498 shares during the period. Institutional investors and hedge funds own 82.65% of the company’s stock.
CME has been the topic of several analyst reports. Royal Bank of Canada increased their target price on shares of CME Group from $135.00 to $147.00 and gave the stock an “outperform” rating in a report on Monday, October 16th. BidaskClub upgraded shares of CME Group from a “hold” rating to a “buy” rating in a report on Tuesday, January 9th. Berenberg Bank initiated coverage on shares of CME Group in a report on Thursday, January 25th. They issued a “hold” rating and a $170.00 target price on the stock. Zacks Investment Research upgraded shares of CME Group from a “hold” rating to a “buy” rating and set a $164.00 target price on the stock in a report on Tuesday, January 2nd. Finally, Barclays increased their target price on shares of CME Group from $139.00 to $149.00 and gave the stock an “overweight” rating in a report on Tuesday, October 10th. Three equities research analysts have rated the stock with a hold rating and eleven have assigned a buy rating to the company’s stock. The stock currently has a consensus rating of “Buy” and an average price target of $155.08.
In related news, insider Jack J. Tobin sold 2,325 shares of the firm’s stock in a transaction on Monday, December 18th. The shares were sold at an average price of $152.28, for a total value of $354,051.00. Following the completion of the transaction, the insider now owns 17,574 shares of the company’s stock, valued at $2,676,168.72. The transaction was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. Also, insider Sunil Cutinho sold 2,600 shares of the firm’s stock in a transaction on Friday, November 17th. The shares were sold at an average price of $139.57, for a total transaction of $362,882.00. Following the completion of the transaction, the insider now directly owns 22,301 shares of the company’s stock, valued at approximately $3,112,550.57. The disclosure for this sale can be found here. In the last ninety days, insiders sold 37,428 shares of company stock valued at $5,527,779. 0.57% of the stock is owned by insiders.
Shares of CME Group Inc (NASDAQ:CME) traded down $0.06 during mid-day trading on Monday, hitting $159.05. 1,309,981 shares of the stock traded hands, compared to its average volume of 1,373,453. The company has a debt-to-equity ratio of 0.10, a current ratio of 1.03 and a quick ratio of 1.05. CME Group Inc has a 52 week low of $114.82 and a 52 week high of $163.00. The company has a market capitalization of $53,956.59, a P/E ratio of 13.34, a price-to-earnings-growth ratio of 2.11 and a beta of 0.64.
CME Group (NASDAQ:CME) last issued its quarterly earnings data on Thursday, February 1st. The financial services provider reported $1.12 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $1.10 by $0.02. The company had revenue of $900.00 million during the quarter, compared to the consensus estimate of $886.85 million. CME Group had a net margin of 111.49% and a return on equity of 7.68%. The firm’s revenue was down 1.4% compared to the same quarter last year. During the same quarter in the prior year, the firm earned $1.14 earnings per share. sell-side analysts predict that CME Group Inc will post 6.28 earnings per share for the current fiscal year.
The firm also recently announced a dividend, which was paid on Tuesday, January 16th. Investors of record on Thursday, December 28th were given a $3.50 dividend. The ex-dividend date was Wednesday, December 27th. This is an increase from CME Group’s previous dividend of $3.25. CME Group’s dividend payout ratio (DPR) is 22.11%.
CME Group Company Profile
CME Group Inc, through its exchanges, provides products across all asset classes, including futures and options based on interest rates, equity indexes, foreign exchange, energy, agricultural products and metals. The Company’s segment primarily consists of the Chicago Mercantile Exchange Inc (CME), Board of Trade of the City of Chicago, Inc (CBOT), New York Mercantile Exchange, Inc (NYMEX) and Commodity Exchange, Inc (COMEX) exchanges.
Want to see what other hedge funds are holding CME? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CME Group Inc (NASDAQ:CME).
Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.